Skip to Content
Merck
  • The endolysosomal adaptor PLEKHM1 is a direct target for both mTOR and MAPK pathways.

The endolysosomal adaptor PLEKHM1 is a direct target for both mTOR and MAPK pathways.

FEBS letters (2021-01-17)
Andrea Gubas, Christina Karantanou, Doris Popovic, Georg Tascher, Marina E Hoffmann, Anna Platzek, Nina Dawe, Ivan Dikic, Daniela S Krause, David G McEwan
ABSTRACT

The lysosome is a cellular signalling hub at the point of convergence of endocytic and autophagic pathways, where the contents are degraded and recycled. Pleckstrin homology domain-containing family member 1 (PLEKHM1) acts as an adaptor to facilitate the fusion of endocytic and autophagic vesicles with the lysosome. However, it is unclear how PLEKHM1 function at the lysosome is controlled. Herein, we show that PLEKHM1 coprecipitates with, and is directly phosphorylated by, mTOR. Using a phosphospecific antibody against Ser432/S435 of PLEKHM1, we show that the same motif is a direct target for ERK2-mediated phosphorylation in a growth factor-dependent manner. This dual regulation of PLEKHM1 at a highly conserved region points to a convergence of both growth factor- and amino acid-sensing pathways, placing PLEKHM1 at a critical juncture of cellular metabolism.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-PLEKHM1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, Ab2
Sigma-Aldrich
Monoclonal Anti-Glutathione-S-Transferase (GST) antibody produced in mouse, clone GST-2, ascites fluid
Sigma-Aldrich
Monoclonal Anti-Vinculin antibody produced in mouse, clone VIN-11-5, ascites fluid
Sigma-Aldrich
Anti-Phosphoserine Antibody, Chemicon®, from rabbit